Halligan the Dalmatian is offering more than just a friendly face in Searsmont, Maine—he’s providing comfort and support to firefighters in need. Guided by his handler, former first responder Timothy Nickels, Halligan represents a new model of emotional care on the front lines.

Repeatedly missing salon appointments has left one woman feeling embarrassed and worried about her relationship with her hairstylist. As her memory lapses pile up, she struggles to address the resulting strain with no clear solution.

In the aftermath of the Lahaina wildfires, a Detox & Wellness Workshop aims to support community-wide healing. Held at the Lahaina Jodo Mission on June 6, the event highlights holistic methods to help residents recover and reconnect.

For years, these two sisters were inseparable, sharing everything from clothes to private jokes. Now, one writes about the distance that has crept in and her longing to rekindle their former closeness. This short plea highlights the fragility of sibling ties and the enduring hope for reconciliation.

A new report highlights more than 75 drugs under consideration for Duchenne muscular dystrophy, promising significant progress in patient care. The analysis explores clinical strategies, upcoming therapies, and commercial prospects, signaling a major shift in the DMD landscape.

Two of Climb Bio’s most promising therapies—CLYM116 and budoprutug—will be in the spotlight at the European Renal Association Congress 2026. The company is sharing early safety data and a Phase 2 trial update in Glasgow, Scotland, detailing its mission to advance treatment options for immune-mediated kidney diseases.

After battling alcohol abuse for ten years, a veteran decided that relying on a friend’s support alone was not enough. He found renewed hope in a VA program that helped him move forward on the path to lasting recovery.

A recent Dear Abby column highlights a dilemma many families face: how to handle a disruptive sibling while preserving long-held family ties. One reader’s wish to keep the peace underscores the complex responsibilities that often accompany familial relationships.

Groundbreaking news from Immusoft reveals the treatment of the world’s first patient with a B cell-based therapy. With support from the FDA and ARM, the company showcases a next-generation approach focusing on scalability and re-dosability.

A newly approved weight-loss drug, Foundayo (orforglipron), has arrived months ahead of schedule after gaining FDA clearance in just 50 days. The swift approval signals a growing momentum in the development of anti-obesity treatments.

Esperion Therapeutics has completed its acquisition of Corstasis Therapeutics, bringing the FDA-approved Enbumyst nasal spray into its cardiovascular portfolio. This first-in-class nasal spray loop diuretic helps manage fluid retention for congestive heart failure, marking a new step in Esperion’s plan to address the growing global burden of cardiometabolic disease. Executives anticipate that Enbumyst will bolster the company’s commercial capabilities and revenue growth.

Neutrolis, Inc. has released positive results from the Phase 1a portion of its LIBERATE-I trial, spotlighting NTR-1011’s potential in dismantling harmful Neutrophil Extracellular Traps (NETs). This first-in-class DNASE1L3 fusion protein aims to address chronic inflammatory pathways without compromising the immune system.

A husband’s affair with a mutual friend has left one marriage reeling and a friendship in turmoil. While the wife has found a path to forgiveness, the news of a baby on the way adds a daunting new twist to an already fragile situation.

A mother in Texas grapples with her daughter’s unfounded blame, while a 35-year-old woman contemplates a life-changing decision about intimacy. Dear Abby offers counsel on confronting false accusations, navigating personal struggles, and acknowledging the significance of Passover.

In this advice-column dilemma, a reader grapples with leaving a spouse after a medical diagnosis. Turning to R. Eric Thomas’s “Asking Eric” column, the individual confronts guilt, responsibility, and the desire for autonomy.

A shocked mother grapples with her 22-year-old daughter’s relationship with a 54-year-old boss. Bound by a promise of secrecy to her older daughter, she struggles to voice her concerns as the family edge closer to a confrontation.

In this opinion piece, the author grapples with a wave of intense sadness while pointing a finger at the internet algorithm. Personal reflections hint at a previous column, underscoring how online content might deepen our emotions in surprising ways.

Brii Biosciences announced full-year 2025 results, emphasizing progress in its hepatitis B treatments and a robust cash position of US$276.1 million. The Company’s Phase 2b HBV trials, ENRICH and ENHANCE, have fully enrolled and are poised for key data readouts in the second half of 2026.

A traveler reveals how her perceived “ugliness” allows her to move through unfamiliar places with less harassment. Her first-person reflection, shared online, shines light on how appearance can influence personal experiences and safety.

Research suggests that the time of day when certain treatments—such as cancer therapies or vaccines—are given can influence their effectiveness. Scientists are examining how the body’s internal clock, or circadian rhythm, might be the key to unlocking better patient outcomes.

IgA nephropathy is a silent attack on the kidneys that often goes unnoticed. With new treatments on the horizon, early diagnosis could save countless lives by preventing further damage and prolonging kidney function.